Skip to main content
. Author manuscript; available in PMC: 2010 Jun 15.
Published in final edited form as: J Infect Dis. 2006 Nov 22;195(1):55–69. doi: 10.1086/509895

Table 3.

Expression levels of 78 genes constituting multiple immune gene networks that were striking up-regulated by bacille Calmette-Guérin (BCG) vaccination/infection.

Gene Gene ratio for BCG
Gene ratio for control
Mean ± SD P Mean ± SD P
IL-1α 4.1 ± 6.5 .490 0.3 ± 0.1 .055
IL-1β 16.4 ± 26.5 .097 1.9 ± 1.4 .527
IL-2 UD UD UD UD
IL-3 113.9 ± 107.0 .028a 1.0 ± 0.1 .714
IL-4 4.3 ± 5.9 .178 1.5 ± 2.7 .827
IL-5 1.1 ± 1.6 .171 1.6 ± 2.1 .680
IL-6 3.0 ± 3.3 .413 1.4 ± 1.1 .734
IL-7 2.5 ± 4.7 .185 1.0 ± 0.1 .721
IL-8 65.1 ± 66.2 .040a 1.0 ± 0.1 .268
IL-9 UD UD UD UD
IL-10 0.4 ± 0.4 .134 1.6 ± 1.4 .565
IL-12α 1.2 ± 1.6 .178 1.0 ± 0.1 .631
IL-12β 1.5 ± 1.6 .197 2.7 ± 2.5 .282
IL-13 1.4 ± 1.7 .209 0.3 ± 0.2 .166
IL-15 10.0 ± 9.5 .029a 1.1 ± 0.1 .153
IL-16 25.9 ± 22.7 .004b 2.3 ± 1.0 .141
IL-17 1.5 ± 1.5 .216 1.0 ± 0.0 .177
IL-18 235.6 ± 335.7 .037a 1.0 ± 0.1 .293
IL-19 UD UD UD UD
IL-20 27.1 ± 30.2 .001b 1.1 ± 0.1 .239
IL-21 4.3 ± 5.4 .456 1.1 ± 0.1 .268
IL-22 115.1 ± 114.8 .005b 2.5 ± 3.6 .930
IL-23α 11.4 ± 7.0 .002b 0.9 ± 0.5 .648
IL-27 8.2 ± 10.8 .027a UD UD
IFN-α 96.3 ± 94.6 .001b 0.9 ± 0.2 .790
IFN-β 66.0 ± 67.5 .000b UD UD
IFN-γ 38.4 ± 37.7 .000b 1.8 ± 0.8 .280
MIF 20.5 ± 23.0 .006b 0.9 ± 0.1 .100
TNF-α 8.1 ± 5.1 .030a 1.8 ± 2.2 .568
IL-1R1 12.9 ± 18.7 .123 0.9 ± 0.4 .544
IL-1R2 1.8 ± 1.8 .323 UD UD
IL-2Rα 8.5 ± 6.9 .129 0.9 ± 0.1 .146
IL-2Rβ 34.1 ± 29.3 .001b 2.3 ± 2.0 .139
IL-2Rγ 39.7 ± 55.6 .070 1.0 ± 0.2 .631
IL-3Rα 44.7 ± 44.9 .001b UD UD
IL-4R 16.8 ± 21.4 .158 1.0 ± 0.1 .593
IL-5Rα 1.4 ± 1.5 .202 1.0 ± 0.2 .478
IL-6R 247.5 ± 168.5 .008b 2.1 ± 1.6 .342
IL-7R 25.6 ± 49.3 .481 1.1 ± 0.2 .805
IL-8Rα 73.0 ± 82.1 .000b UD UD
IL-9R 1.4 ± 1.4 .238 1.4 ± 1.2 .459
IL-10Rα 9.0 ± 12.5 .124 0.5 ± 0.3 .148
IL-10Rβ 5.0 ± 7.1 .291 1.1 ± 0.1 .147
IL-11Rα 40.5 ± 43.0 .001b 1.3 ± 1.0 .982
IL-12Rβ1 4.0 ± 2.8 .179 1.8 ± 1.1 .172
IL-12Rβ2 2.8 ± 1.9 .427 1.0 ± 0.1 .897
IL-13Rα1 119.6 ± 182.0 .003b 1.0 ± 0.1 .683
IL-15Rα 3.0 ± 3.0 .249 2.6 ± 2.6 .135
IL-17R 19.5 ± 19.6 .247 1.3 ± 0.4 .503
IL-18R1 134.0 ± 110.4 .002b 1.0 ± 0.0 .977
IL-21R 5.6 ± 8.4 .266 1.0 ± 0.1 .682
IFN-γR 76.7 ± 75.8 .001b 3.2 ± 3.5 .392
TNFR 18.5 ± 27.5 .005b UD UD
CCL27 9.7 ± 10.1 .004b 1.5 ± 1.7 .910
CCL28 87.5 ± 133.4 .003b 1.8 ± 2.5 .833
CXCL11 1.6 ± 2.1 .179 1.0 ± 0.0 .956
CXCL12 1.2 ± 1.5 .181 1.0 ± 0.1 .364
EOTAXIN UD UD 1.0 ± 0.1 .787
Eta-1 1.1 ± 1.2 .178 1.0 ± 0.1 .374
FRA 28.1 ± 41.8 .001b 1.0 ± 0.0 .110
GCP2 107.0 ± 155.1 .002b 1.2 ± 0.6 .936
IP-10 26.0 ± 22.3 .430 2.7 ± 3.5 .882
LARC 1.2 ± 1.5 .149 1.0 ± 0.1 .253
MCP1 18.0 ± 7.4 .003b UD UD
MCP2 21.9 ± 29.3 .007b 1.0 ± 0.1 .566
MCP3 2.1 ± 1.7 .279 1.0 ± 0.1 .475
MCP4 1.7 ± 1.8 .208 1.0 ± 0.1 .241
MDC 15.3 ± 20.8 .017b UD UD
MIP-1α 3.4 ± 0.8 .010b 0.9 ± 0.1 .183
MIP-1β 62.7 ± 49.0 .123 1.0 ± 0.0 .725
MIP-3β 1.2 ± 1.6 .183 1.0 ± 0.1 .307
PARC 10.8 ± 14.8 .092 1.7 ± 2.1 .807
RANTES 3.4 ± 0.8 .010a 1.0 ± 0.1 .871
TARC 1.4 ± 1.6 .216 1.0 ± 0.1 .422
TECK 17.7 ± 23.5 .001b 1.7 ± 1.7 .795
CCR1 12.0 ± 5.5 .000b 1.4 ± 0.5 .682
CCR2 21.9 ± 20.6 .003b 1.7 ± 1.2 .779
CCR3 9.8 ± 4.3 .001b 1.9 ± 3.0 .922
CCR4 51.8 ± 51.7 .141 1.1 ± 0.1 .434
CCR5 263.2 ± 459.1 .019a 2.8 ± 3.5 .668
CCR6 51.4 ± 89.6 .008b UD UD
CCR7 5.7 ± 6.7 .006b 2.6 ± 2.4 .082
CCR8 37.7 ± 37.4 .000b 1.2 ± 1.4 .939
CCR9 49.4 ± 49.0 .001b 1.5 ± 2.0 .926
CCR10 45.2 ± 38.2 .000b UD UD
CCR11 18.7 ± 29.6 .002b 3.8 ± 4.7 .671
CX3CR1 54.4 ± 47.3 .000b UD UD
CXCR3 5.3 ± 4.5 .022a 1.3 ± 1.3 .893
CXCR4 10.1 ± 5.9 .002b 1.0 ± 0.2 .276
CXCR5 4.4 ± 6.2 .336 1.7 ± 1.4 .432
CXCR6 17.5 ± 13.8 .010a 3.2 ± 2.3 .136
XCR1 26.5 ± 32.0 .000b 3.1 ± 4.6 .945
ANGPT UD UD 1.0 ± 0.0 .436
FGF18 3.0 ± 3.6 .311 0.9 ± 1.5 .554
FGF2 UD UD 1.4 ± 1.3 .873
IGF1 1.5 ± 2.2 .198 3.0 ± 4.8 .842
TGFα 1.4 ± 1.5 .211 2.7 ± 3.9 .428
TGFβ1 2.4 ± 2.4 .329 3.5 ± 2.6 .154
VEGF 90.8 ± 128.7 .001b 1.1 ± 0.1 .225
C-MAF 127.6 ± 214.5 .000b UD UD
GATA-3 16.8 ± 21.4 .158 UD UD
PU.1 73.9 ± 70.6 .010a 1.7 ± 1.7 .451
SCM1 14.2 ± 11.2 .001b 0.7 ± 0.9 .991
T-bet 14.9 ± 14.6 .007b 1.8 ± 1.4 .855
B7-1 11.5 ± 21.9 .144 1.0 ± 0.1 .494
B7-2 272.8 ± 522.8 .038a 2.8 ± 3.1 .735
CD28 603.9 ± 945.1 .003b 0.7 ± 0.4 .411
CTLA4 12.2 ± 8.3 .004b 0.8 ± 0.7 .602
ICOS 23.8 ± 35.3 .093 1.0 ± 0.0 .196
ICOSL 5.5 ± 6.5 .177 0.7 ± 0.4 .150
CTSG 9.4 ± 9.8 .001b 2.5 ± 2.9 .412
GZMA 260.7 ± 306.5 .021a 2.3 ± 2.1 .269
GZMB 30.0 ± 28.8 .000b UD UD
GZMK 104.0 ± 83.0 .000b 1.8 ± 1.0 .292
GZMM 41.3 ± 45.0 .001b 0.9 ± 0.7 .628
MMP-9 22.2 ± 24.0 .008b 0.9 ± 0.5 .366
UBP43 9.3 ± 10.7 .026a 1.0 ± 0.1 .497
TIM1 5.1 ± 4.0 .002b 1.4 ± 1.7 .815
TIM3 3.1 ± 1.7 .264 0.5 ± 0.2 .060
EMAP2 10.5 ± 16.4 .175 2.6 ± 3.1 .428
GNLY 15.3 ± 27.9 .165 0.9 ± 0.1 .191
ICAM-1 17.7 ± 24.3 .020a 1.0 ± 0.1 .842
PD1 39.4 ± 47.3 .025a 1.7 ± 1.8 .976
SLPI 45.2 ± 56.6 .000b 1.1 ± 0.0 .105
ECF-L 3.0 ± 3.6 .311 UD UD
EDN1 11.5 ± 11.4 .031a 1.0 ± 0.0 .753
FasL 4.6 ± 6.4 .483 0.5 ± 0.2 .043
ISG15 54.4 ± 31.8 .019a 1.0 ± 0.0 .793
MPIF1 1.3 ± 1.5 .198 1.4 ± 2.1 .411
PDL1 15.4 ± 16.9 .059 UD UD
PDL2 52.9 ± 39.0 .031a 2.0 ± 2.6 .858
PRF1 43.9 ± 62.8 .000b 2.7 ± 2.3 .413
STAT1 164.2 ± 133.7 .000b 1.0 ± 0.1 .388
STAT6 28.9 ± 48.0 .141 1.0 ± 0.1 .519
TLR2 33.9 ± 29.2 .008b 1.0 ± 0.1 .668

NOTE. Peripheral-blood lymphocytes (PBLs) were collected from 4 rhesus monkeys before (week 0) and after (week 5) BCG vaccination/infection and assessed for global gene expression by a large-scale real-time quantitation system. Earlier studies had shown peak T cell responses and anti-BCG immunity occurring 5 weeks after intravenous BCG inoculation [1416]. BCG data show the means of fold changes in expression levels for week 5 vs. week 0 in PBLs from the 4 BCG-vaccinated monkeys. P values for IL-1, IL-2, IL-4, IL-5, IL-6, and IL-9 were >.05 at this 5-week time point but were <.05 in the longitudinal analysis (table 4). As validation, the control data show the means of fold changes in expression levels for week 2 vs. week 0 in PBLs from 4 normal, uninfected rhesus macaques that received saline. UD, undetectable.

a

P < .05.

b

P < .01.